Danielle Denison
Patient Engagement Lead, Hemophilia Pfizer
As the US Pfizer Patient Engagement Lead for Hemophilia in Specialty Care, Danielle’s core mission is fostering alliances with internal peers and outside allies to create game-changing progress that uplifts those battling rare disorders and long-term health issues. The heavy personal and communal strain from these ailments inspires unwavering dedication from Danielle and her whole specialty care team.
Spanning 29 years in industry, her path has encompassed diverse responsibilities in sales, advocacy for patients, interactions with payers, marketing, and enablement—centered on rare and chronic disease fields. This wide-ranging exposure has sharpened her insights into the full spectrum of turning discoveries into tangible benefits for those in need. What excites her most is assembling and nurturing inclusive, elite teams that excel in rolling out pioneering medicines and redefining patient pathways.
Right now, she is honored to guide the evolution of Pfizer’s forward-thinking Specialty Care offerings, in a position that resonates deeply with her beliefs. The connections forged, hurdles cleared, and lives touched along the way fill her with profound thanks for this inspiring adventure.
Seminars
- Quantifying patient connection and activation through opt-in rates, sustained navigator engagement, and community-specific adoption trends
- Measuring educational impact using pre- and post-program analytics that capture increases in treatment awareness, confidence, and intention to initiate therapy
- Using compliant, aggregated CRM insights to track behavior change, treatment comprehension, and community-level patterns while navigating legal and data-sharing constraints
- Translating these insights into clear, evidence-based narratives that demonstrate value, secure leadership buy-in, and guide resourcing decisions for scalable patient-focused models
